The clinical phase III trials of the Covid-19 nasal vaccination have been finished, according to Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, who stated the company will submit its data to the Drugs Controller General of India (DCGI) next month. Ella remarked, “We recently concluded a clinical experiment and are currently analysing…
The national drug regulator has recently granted the emergency use authorisation (EUA) to Bharat Biotech Covaxin for children belonging to the age group of 6 to 12 years. This will now rollout the need for vaccinating children under the age of 12. India has been consistently rolling out the Covid-19 vaccines based on epidemiological…
In order to scale up production of Covid-19 vaccines, scaling up partnerships, technology transfers and supply of various critical equipment and materials is necessary to cater to the huge demand for vaccines said Bharat Biotech Joint MD Suchitra Ella on Saturday. Ella, speaking at the EU-India Business Roundtable said that more emphasis should be on fostering…